F

Amicus Therapeutics
D

FOLD

9.16000
USD
0.10
(1.05%)
مغلق
حجم التداول
76,233
الربح لكل سهم
0
العائد الربحي
-
P/E
-51
حجم السوق
2,749,063,302
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ARWR
    -1.040
    (-4.97%)
    19.900 USD
    B
    BLUE
    -2.93000
    (-41.68%)
    4.10000 USD
    C
    CRSP
    -2.620
    (-5.19%)
    47.840 USD
    E
    EDIT
    -0.14000
    (-6.80%)
    1.92000 USD
    N
    NTLA
    -0.075
    (-0.61%)
    12.180 USD
    Q
    QURE
    -0.130
    (-1.00%)
    12.840 USD
    S
    SGMO
    -0.04500
    (-4.00%)
    1.08000 USD
    S
    SRPT
    -2.010
    (-1.86%)
    106.280 USD
    VRTX
    VRTX
    4.10
    (0.85%)
    484.53 USD
    المزيد
الأخبار
المقالات

العنوان: Amicus Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants;a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.